Merck combines a powerful oncology franchise, substantial cash generation, and a promising drug pipeline, but its valuation and dependence on successfully replacing future KEYTRUDA revenue limit the current margin of safety.
Hold-rated reports
904 tickers rated HoldMasTec is positioned to benefit from multiyear grid modernization and critical electrical infrastructure investment, but acquisition integration, uneven margins and working-capital volatility may limit returns despite its expanding backlog.
WEC Energy offers durable regulated utility earnings, growing electricity demand and reliable dividends, but heavy capital requirements, leverage and a demanding valuation constrain shareholder upside.
Mirion benefits from long-term nuclear safety and radiation technology demand, supported by accelerating orders and cash generation, but acquisition-related dilution, leverage, and a demanding earnings multiple limit near-term upside.
Floor & Decor can compound through specialty flooring market-share gains, national store expansion, and professional customer growth, but weak renovation demand and capital-intensive expansion constrain near-term returns.
Smurfit Westrock offers global packaging scale, dividend income, and earnings-recovery potential through pricing and integration gains, but weak capital returns, leverage, and volatile input costs constrain its valuation upside.
UBS can compound earnings through global wealth-management growth and Credit Suisse integration savings, but demanding book-value multiples and potentially higher Swiss capital requirements constrain shareholder upside.
International Paper offers a cyclical earnings recovery opportunity through North American margin improvement and an EMEA separation, but weak free cash flow, substantial debt, and restructuring uncertainty constrain the upside case.
Antero Midstream offers durable Appalachian natural gas infrastructure cash flows, a meaningful dividend, and acquisition-driven growth opportunities, but customer concentration and an elevated historical valuation constrain its margin of safety.
Everest offers substantial reinsurance earnings capacity and shareholder returns at a modest book-value premium, but recurring casualty reserve deterioration and catastrophe exposure threaten sustainable profitability.
Bunge's enlarged agricultural network and modest forward valuation offer recovery potential through Viterra synergies and improved processing margins, but negative cash conversion and elevated leverage remain significant constraints.
Nomura's expanding wealth-management fees and improving ROE support sustainable earnings growth, but elevated historical book valuation and volatile wholesale trading profits limit the current margin of safety.